Overview

Post-Marketing Surveillance on Long-Term Drug Use of Kiklin (Bixalomer)® Capsules in Patients With Hyperphosphatemia Receiving Peritoneal Dialysis

Status:
Completed
Trial end date:
2019-12-31
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy of long-term use of Kiklin® Capsules in actual clinical settings.
Details
Lead Sponsor:
Astellas Pharma Inc